Science Says

Tuesday, February 23, 2021

Progress on the Pandemic: A year of tackling COVID-19

Get real-time updates from the front lines of science, including:

  • What you need to know about vaccines, including considerations for cancer patients
  • The latest on emerging treatments
  • How the virus is evolving and why it matters

As always, we'll leave plenty of time to answer your questions.

Fred Hutch is at the center of a nonstop scientific sprint to understand and stop the coronavirus. Join us Tuesday, February 23, for Science Says, our monthly researcher roundtable, to meet scientists who are leading vaccine trials, guiding public health policy, tracking genetic changes to the virus, and studying new treatments for COVID-19. 

Please  RSVP by Monday, February 22. After you register, you will receive instructions for how to join the conversation by computer, tablet, or phone.

Date:
Tuesday, February 23, 2021
Start Time:
9 a.m. PST
Location:
Virtual
Speaker or Presenter:
Drs. Thomas Lynch Jr., Michele Andrasik, Trevor Bedford, Larry Corey, and Josh Schiffer

Speakers

Dr. Thomas J. Lynch Jr.

Dr. Thomas J. Lynch Jr.

Dr. Thomas J. Lynch Jr., who will lead the conversation, is Fred Hutch president and holder of the Raisbeck Endowed Chair. He is a lung cancer physician and scientist who is respected worldwide for his pioneering role in precision medicine and his leadership in academic medicine and industry. He joined Fred Hutch one year ago — just weeks before COVID-19 shutdowns began — and has guided the organization’s response to the pandemic with urgency, compassion, and a commitment to sparking scientific solutions

Dr. Michele Andrasik

Dr. Michele Andrasik

Dr. Michele Andrasik is one of the directors of the COVID-19 Prevention Network (CoVPN), which is conducting Phase 3 efficacy trials for vaccines as part of Operation Warp Speed. She has worked to ensure that communities hit hardest by COVID-19 are adequately represented in vaccine trials, and she helps create educational materials to increase understanding and uptake of approved vaccines.

Dr. Trevor Bedford

Dr. Trevor Bedford

Dr. Trevor Bedford is a computational biologist who has been at the forefront of tracking the virus that causes COVID-19 since it emerged. His expertise and insight, along with the software tool he co-developed, Nextstrain, have been instrumental to understanding the rapid spread and evolution of the coronavirus — and have earned him nearly 300,000 followers on Twitter.

Dr. Larry Corey

Dr. Larry Corey

Dr. Larry Corey is a world-renowned virologist, principal investigator of the HIV Vaccine Trials Network, and Fred Hutch president and director emeritus. As head of the COVID-19 Prevention Network operations center, located at Fred Hutch, and co-leader of the network’s massive clinical trials program, he plays a critical role in Operation Warp Speed, the nation’s monumental effort to develop, test, and distribute vaccines in record time.

Dr. Josh Schiffer

Dr. Josh Schiffer

Dr. Josh Schiffer is an infectious disease physician who uses computer modeling to study COVID-19 transmission and super-spreading. His research has reinforced the importance of widespread masking and testing, and he is a strong advocate for developing treatments that interrupt COVID-19 early in the course of infection. Dr. Schiffer is one of many researchers leading clinical trials at Fred Hutch’s new COVID-19 Clinical Research Center

Last Modified, March 12, 2021